| 000 | 01382 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515012510.0 | ||
| 264 | 0 | _c20060301 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0160-6689 | ||
| 024 | 7 |
_a10.4088/jcp.v66n1219c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZacher, Jennifer L | |
| 245 | 0 | 0 |
_aHypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _cDec 2005 |
||
| 300 |
_a1614-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzodiazepines _xadverse effects |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xadverse effects |
| 650 | 0 | 4 |
_aHypotension _xchemically induced |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aLorazepam _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 |
_aSchizophrenia, Paranoid _xdrug therapy |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aRoche-Desilets, Jennifer | |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 66 _gno. 12 _gp. 1614-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4088/jcp.v66n1219c _zAvailable from publisher's website |
| 999 |
_c16018430 _d16018430 |
||